Pulmonary Embolism Therapeutics Market - Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: PFA1063E32E4EN
Market Monitor Global

Abstracts

Lifestyle associated factors such as smoking, overweight, old-age pregnancy, and excessive use of estrogen supplements are some of the major causes of pulmonary embolism.

This report contains market size and forecasts of Pulmonary Embolism Therapeutics in Global, including the following market information:

Global Pulmonary Embolism Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Pulmonary Embolism Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pulmonary Embolism Therapeutics include Boehringer Ingelheim International, Bristol-Myers Squibb, Daiichi Sankyo, F. Hoffmann-La Roche and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pulmonary Embolism Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pulmonary Embolism Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Pulmonary Embolism Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Oral
• Parenteral

Global Pulmonary Embolism Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Pulmonary Embolism Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Adult
• Child

Global Pulmonary Embolism Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Pulmonary Embolism Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pulmonary Embolism Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Pulmonary Embolism Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Boehringer Ingelheim International
• Bristol-Myers Squibb
• Daiichi Sankyo
• F. Hoffmann-La Roche
• Johnson & Johnson

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pulmonary Embolism Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pulmonary Embolism Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PULMONARY EMBOLISM THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Pulmonary Embolism Therapeutics Market Size: 2021 VS 2028
2.2 Global Pulmonary Embolism Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Pulmonary Embolism Therapeutics Players in Global Market
3.2 Top Global Pulmonary Embolism Therapeutics Companies Ranked by Revenue
3.3 Global Pulmonary Embolism Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Pulmonary Embolism Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pulmonary Embolism Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pulmonary Embolism Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Pulmonary Embolism Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Pulmonary Embolism Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Pulmonary Embolism Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Parenteral
4.2 By Type - Global Pulmonary Embolism Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Pulmonary Embolism Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Pulmonary Embolism Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Pulmonary Embolism Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pulmonary Embolism Therapeutics Market Size, 2021 & 2028
  5.1.2 Adult
  5.1.3 Child
5.2 By Application - Global Pulmonary Embolism Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Pulmonary Embolism Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Pulmonary Embolism Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Pulmonary Embolism Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Pulmonary Embolism Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Pulmonary Embolism Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Pulmonary Embolism Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Pulmonary Embolism Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Pulmonary Embolism Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Pulmonary Embolism Therapeutics Revenue, 2017-2028
  6.3.2 US Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.3.3 Canada Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Pulmonary Embolism Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Pulmonary Embolism Therapeutics Revenue, 2017-2028
  6.4.2 Germany Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.4.3 France Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.4.5 Italy Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.4.6 Russia Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Pulmonary Embolism Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Pulmonary Embolism Therapeutics Revenue, 2017-2028
  6.5.2 China Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.5.3 Japan Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.5.6 India Pulmonary Embolism Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Pulmonary Embolism Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Pulmonary Embolism Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Pulmonary Embolism Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.7.3 Israel Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Pulmonary Embolism Therapeutics Market Size, 2017-2028
  6.7.5 UAE Pulmonary Embolism Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Boehringer Ingelheim International
  7.1.1 Boehringer Ingelheim International Corporate Summary
  7.1.2 Boehringer Ingelheim International Business Overview
  7.1.3 Boehringer Ingelheim International Pulmonary Embolism Therapeutics Major Product Offerings
  7.1.4 Boehringer Ingelheim International Pulmonary Embolism Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Boehringer Ingelheim International Key News
7.2 Bristol-Myers Squibb
  7.2.1 Bristol-Myers Squibb Corporate Summary
  7.2.2 Bristol-Myers Squibb Business Overview
  7.2.3 Bristol-Myers Squibb Pulmonary Embolism Therapeutics Major Product Offerings
  7.2.4 Bristol-Myers Squibb Pulmonary Embolism Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Bristol-Myers Squibb Key News
7.3 Daiichi Sankyo
  7.3.1 Daiichi Sankyo Corporate Summary
  7.3.2 Daiichi Sankyo Business Overview
  7.3.3 Daiichi Sankyo Pulmonary Embolism Therapeutics Major Product Offerings
  7.3.4 Daiichi Sankyo Pulmonary Embolism Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Daiichi Sankyo Key News
7.4 F. Hoffmann-La Roche
  7.4.1 F. Hoffmann-La Roche Corporate Summary
  7.4.2 F. Hoffmann-La Roche Business Overview
  7.4.3 F. Hoffmann-La Roche Pulmonary Embolism Therapeutics Major Product Offerings
  7.4.4 F. Hoffmann-La Roche Pulmonary Embolism Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 F. Hoffmann-La Roche Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson Pulmonary Embolism Therapeutics Major Product Offerings
  7.5.4 Johnson & Johnson Pulmonary Embolism Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Johnson & Johnson Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Pulmonary Embolism Therapeutics Market Opportunities & Trends in Global Market
Table 2. Pulmonary Embolism Therapeutics Market Drivers in Global Market
Table 3. Pulmonary Embolism Therapeutics Market Restraints in Global Market
Table 4. Key Players of Pulmonary Embolism Therapeutics in Global Market
Table 5. Top Pulmonary Embolism Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pulmonary Embolism Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pulmonary Embolism Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pulmonary Embolism Therapeutics Product Type
Table 9. List of Global Tier 1 Pulmonary Embolism Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pulmonary Embolism Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pulmonary Embolism Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pulmonary Embolism Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pulmonary Embolism Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pulmonary Embolism Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pulmonary Embolism Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pulmonary Embolism Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Boehringer Ingelheim International Corporate Summary
Table 31. Boehringer Ingelheim International Pulmonary Embolism Therapeutics Product Offerings
Table 32. Boehringer Ingelheim International Pulmonary Embolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Pulmonary Embolism Therapeutics Product Offerings
Table 35. Bristol-Myers Squibb Pulmonary Embolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Daiichi Sankyo Corporate Summary
Table 37. Daiichi Sankyo Pulmonary Embolism Therapeutics Product Offerings
Table 38. Daiichi Sankyo Pulmonary Embolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. F. Hoffmann-La Roche Corporate Summary
Table 40. F. Hoffmann-La Roche Pulmonary Embolism Therapeutics Product Offerings
Table 41. F. Hoffmann-La Roche Pulmonary Embolism Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Pulmonary Embolism Therapeutics Product Offerings
Table 44. Johnson & Johnson Pulmonary Embolism Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Pulmonary Embolism Therapeutics Segment by Type in 2021
Figure 2. Pulmonary Embolism Therapeutics Segment by Application in 2021
Figure 3. Global Pulmonary Embolism Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pulmonary Embolism Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pulmonary Embolism Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pulmonary Embolism Therapeutics Revenue in 2021
Figure 8. By Type - Global Pulmonary Embolism Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pulmonary Embolism Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pulmonary Embolism Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pulmonary Embolism Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pulmonary Embolism Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pulmonary Embolism Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pulmonary Embolism Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pulmonary Embolism Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pulmonary Embolism Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Boehringer Ingelheim International Pulmonary Embolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Pulmonary Embolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Daiichi Sankyo Pulmonary Embolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. F. Hoffmann-La Roche Pulmonary Embolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Pulmonary Embolism Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)